# Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases

> **NCT00049361** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Brain and Central Nervous System Tumors
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** temozolomide
- **DRUG:** thalidomide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00049361
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01-01
- **Primary completion:** 2004-12-07
- **Final completion:** 2004-12-07
- **Target enrollment:** — (—)
- **Last updated:** 2021-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00049361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00049361, "Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00049361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*